# Effect of Foot Orthoses on Midfoot Pain and the Volume of Bone Marrow Lesions in the Midfoot: A Randomized Mechanism of Action Study

**Authors:** Jill Halstead, Anne‐Maree Keenan, Philip G. Conaghan, Dennis McGonagle, Anthony C. Redmond

PMC · DOI: 10.1002/acr.25648 · Arthritis Care & Research · 2025-12-08

## TL;DR

Foot orthoses reduce midfoot pain and shrink bone marrow lesions more effectively than control insoles in people with midfoot pain.

## Contribution

This study demonstrates that foot orthoses can reduce bone marrow lesion volume, supporting their mechanism of action in pain relief.

## Key findings

- Foot orthoses significantly reduced pain more than control insoles at 6 and 12 weeks.
- The orthoses group showed greater reduction in bone marrow lesion volume compared to the control group.
- Functional impairment improved more in the orthoses group at 6 weeks.

## Abstract

Foot orthoses are thought to improve pain by potentially modifying internal mechanical forces. To test this, we explored whether foot orthoses can modify patterns of bone marrow lesions (BMLs) in people with midfoot pain.

Forty‐two people were recruited with midfoot pain, and magnetic resonance imaging–confirmed midfoot BMLs. Participants were randomized (2:1 ratio) to receive either pre‐formed orthoses (n = 27) or control cushioning insoles (n = 15). Outcomes included foot pain (visual analog scale [VAS]), pain and functional impairment subscales of the Manchester Foot Pain and Disability Index, and BML volume measured at baseline and 12 weeks.

In total 108 bones in the midfoot were identified with BMLs (mean 2.5 bones, SD 1.6). In the orthoses group, pain significantly reduced at 6 weeks (mean VAS = −14.8 mm, confidence interval [CI] −22.3 to −7.3) and 12 weeks (mean VAS = −7.1 mm, CI −15.0 to −0.9) compared to the control group at 6 weeks (mean VAS = −7.4 mm, CI −19.9 to 5.2) and 12 weeks (mean VAS = 2.8 mm, CI −9.1 to 14.7). In the orthoses group, functional impairment and pain impairment were significantly reduced at 6 weeks and to a lesser extent at 12 weeks. In the control group, only the functional impairment reduced significantly at 6 weeks. At 12 weeks, BML volume reduced more in the orthoses group (−1544.4 mm3, CI −3660.4 to 571.6), compared to the control group (−315.8 mm3, CI −1528.2 to 896.7).

The foot orthoses group showed a greater reduction in foot pain and a greater reduction in the volume of BMLs compared with the control group.

## Full-text entities

- **Diseases:** functional impairment (MESH:D003072), BMLs (MESH:D001855), Foot Pain (MESH:D010146), pain impairment (MESH:D013001)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13034095/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13034095/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC13034095/full.md

---
Source: https://tomesphere.com/paper/PMC13034095